CC BY-NC-ND 4.0 · International Journal of Practical Otolaryngology 2021; 04(01): e11-e16
DOI: 10.1055/s-0041-1722857
Original Article

Clinical Study of 107 Hospitalized Patients with Peritonsillar Abscess

Risa Wakisaka
1  Department of Otolaryngology—Head and Neck Surgery, Asahikawa Medical University, Hokkaido, Japan
,
Takumi Kumai
1  Department of Otolaryngology—Head and Neck Surgery, Asahikawa Medical University, Hokkaido, Japan
2  Department of Innovative Head and Neck Cancer Research and Treatment (IHNCRT), Asahikawa Medical University, Hokkaido, Japan
,
Kan Kishibe
1  Department of Otolaryngology—Head and Neck Surgery, Asahikawa Medical University, Hokkaido, Japan
,
Miki Takahara
1  Department of Otolaryngology—Head and Neck Surgery, Asahikawa Medical University, Hokkaido, Japan
,
Akihiro Katada
1  Department of Otolaryngology—Head and Neck Surgery, Asahikawa Medical University, Hokkaido, Japan
,
Tatsuya Hayashi
1  Department of Otolaryngology—Head and Neck Surgery, Asahikawa Medical University, Hokkaido, Japan
2  Department of Innovative Head and Neck Cancer Research and Treatment (IHNCRT), Asahikawa Medical University, Hokkaido, Japan
,
Yasuaki Harabuchi
1  Department of Otolaryngology—Head and Neck Surgery, Asahikawa Medical University, Hokkaido, Japan
› Author Affiliations

Abstract

We conducted a retrospective analysis of the data of 107 cases of peritonsillar abscess treated at our hospital between January 2014 and December 2018. Data on age, sex, affected site, duration of hospitalization, method of drainage, presence/absence of laryngeal edema, antibacterial drugs used, and isolated bacteria were analyzed. Of the 107 patients, 71 were males and 36 were females; the median age was 44 years (range: 18–88 years).The left side was affected in 55 patients, the right side in 50 patients, and both sides in two patients. The abscess was localized in the superior pole in 71 patients, and in the inferior pole in 36 patients. Thirty-five patients had laryngeal edema, of which three underwent tracheotomy. Recurrence of the abscess was observed in 15 cases, with the recurrence developing within 3 months in 7 cases, and over a period of 3 years in 4 cases. As for the sensitivity of the causative bacteria to antibacterial drugs, 17% of the causative bacteria showed resistance to clindamycin, while none showed resistance to ampicillin/sulbactam (ABPC/SBT). We concluded that ABPC/SBT might be suitable for the initial treatment of peritonsillar abscess, and that we need to bear in mind the possibility of long-term recurrence.



Publication History

Received: 19 May 2020

Accepted: 13 August 2020

Publication Date:
20 January 2021 (online)

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany